Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$820M |
| 2 |
Palo Alto Networks
PANW
|
+$358M |
| 3 |
Visa
V
|
+$355M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Citigroup
C
|
+$325M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$722M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$356M |
| 3 |
Alibaba
BABA
|
+$345M |
| 4 |
EOG Resources
EOG
|
+$344M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Consumer Discretionary | 17.25% |
| 3 | Communication Services | 14.3% |
| 4 | Technology | 13.13% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Thermo Fisher Scientific
TMO
$214B
| $56.6M | 0.06% |
462,805
-151,357
| -25% | -$19.7M |
|
277
RH
RH
$3.15B
| $56.5M | 0.06% |
605,908
-113,241
| -16% | -$11.1M |
|
|
WCC
278
WESCO International
WCC
$16.7B
| $56.2M | 0.06% |
1,209,848
-476,386
| -28% | -$27.6M |
|
|
CPN
279
DELISTED
Calpine Corporation
CPN
| $56.2M | 0.06% |
3,848,463
-838,617
| -18% | -$13.8M |
|
|
ESRX
280
DELISTED
Express Scripts Holding Company
ESRX
| $55.9M | 0.06% |
690,758
+329,073
| +91% | +$28.7M |
|
|
FOLD
281
DELISTED
Amicus Therapeutics
FOLD
| $55.8M | 0.06% |
3,990,817
+618,822
| +18% | +$9.71M |
|
282
Live Nation Entertainment
LYV
$42.7B
| $55.7M | 0.06% |
2,316,739
+228,739
| +11% | +$5.87M |
|
283
Guidewire Software
GWRE
$12.8B
| $55.5M | 0.06% |
1,055,461
+48,560
| +5% | +$2.69M |
|
284
Pebblebrook Hotel Trust
PEB
$2.12B
| $55.2M | 0.06% |
1,556,354
-83,852
| -5% | -$3.37M |
|
285
Bausch Health
BHC
$2.25B
| $55M | 0.06% |
308,200
+2,364
| +0.8% | +$551K |
|
|
RYL
286
DELISTED
RYLAND GROUP INC
RYL
| $54.6M | 0.06% |
1,337,893
+389,338
| +41% | +$17.4M |
|
287
Avient
AVNT
$3.36B
| $54.3M | 0.06% |
1,851,462
-95,099
| -5% | -$3.21M |
|
288
Texas Instruments
TXN
$255B
| $54.2M | 0.06% |
+1,094,310
| New | +$53.4M |
|
289
Range Resources
RRC
$9.24B
| $53.7M | 0.06% |
1,670,846
-86,388
| -5% | -$3.37M |
|
|
CEB
290
DELISTED
CEB Inc.
CEB
| $53.1M | 0.05% |
777,214
-10,406
| -1% | -$804K |
|
|
NFX
291
DELISTED
Newfield Exploration
NFX
| $52.7M | 0.05% |
1,602,580
+218,509
| +16% | +$7.33M |
|
292
Clearway Energy Class C
CWEN
$4.94B
| $52.4M | 0.05% |
4,517,350
-17,979
| -0.4% | -$311K |
|
293
NN Inc
NNBR
$257M
| $52.4M | 0.05% |
2,833,931
+382,222
| +16% | +$8.87M |
|
|
CSOD
294
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $52M | 0.05% |
1,577,115
+136,111
| +9% | +$4.97M |
|
295
Curtiss-Wright
CW
$26.5B
| $51.8M | 0.05% |
830,399
-61,107
| -7% | -$4.11M |
|
|
DBD
296
DELISTED
Diebold Nixdorf Incorporated
DBD
| $51.7M | 0.05% |
1,735,674
+378,038
| +28% | +$12.3M |
|
297
Chevron
CVX
$383B
| $51.7M | 0.05% |
654,859
-7,659
| -1% | -$645K |
|
|
CMCSK
298
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $51.6M | 0.05% |
901,291
-136,824
| -13% | -$7.83M |
|
299
Exelon
EXC
$46.6B
| $51.4M | 0.05% |
2,428,582
-1,805,415
| -43% | -$40.6M |
|
300
TechnipFMC
FTI
$27.5B
| $51.3M | 0.05% |
2,222,172
+625,397
| +39% | +$15.7M |
|
Similar funds
Jennison Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Jennison Associates held 813 positions worth $97.6B, down 11% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q3 2015 filing shows 84 new, 272 increased, 353 reduced and 92 closed positions. Its largest new stake was Palo Alto Networks: 12,124,434 shares worth $348M. The largest sale was Gilead Sciences, an estimated $722M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2015 buy was Palo Alto Networks: 12,124,434 shares worth $348M.
- Jennison Associates added most to Alphabet (Google) Class C in Q3 2015, an estimated $820M increase.
- Jennison Associates's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $722M.
- Jennison Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $144M.
- Jennison Associates's ten largest holdings make up 24% of its $97.6B portfolio in Q3 2015.
- Jennison Associates opened 84 new positions and closed 92 in Q3 2015.
- Jennison Associates's portfolio value fell 11% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.